PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Rosica Strategic Public Relations

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Secure Symbology, Inc. Introduces New Technology – Protects Consumers from Counterfeit Prescription Drugs - To address the growing concern of counterfeit prescription drugs, Secure Symbology, an innovative New Jersey-based company, has successfully developed and implemented the only tested and proven anti-counterfeiting solution available
Secure Symbology, Inc. Introduces New Technology – Protects Consumers from Counterfeit Prescription Drugs

 

NewswireToday - /newswire/ - Paramus, NJ, United States, 2008/01/28 - To address the growing concern of counterfeit prescription drugs, Secure Symbology, an innovative New Jersey-based company, has successfully developed and implemented the only tested and proven anti-counterfeiting solution available.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Counterfeiting of prescription medications is a serious issue that poses a real threat to the unsuspecting public, and many consumers who rely on prescription medications have suffered catastrophic consequences to their health by consuming fake, or even toxic, prescriptions.

To address this growing concern, Secure Symbology, an innovative New Jersey-based company, has successfully developed and implemented the only tested and proven anti-counterfeiting solution available. The company’s life-saving system makes use of barcode technology, a time-tested answer to the problem of tracking and verification, to authenticate prescription drugs - more reliable and cost effective than Radio Frequency Identification (RFID) or other alternatives currently being investigated. To ensure its successful adoption, the company has also created proprietary software capable of interfacing with any manufacturer’s packaging process and systems.

The U.S. Chamber of Commerce and the International Anti-Counterfeiting Coalition calculate that global counterfeit sales equal $600 to $650 billion a year. This means not only lost revenues for pharmaceutical companies but the negative perception of the entire industry. Secure Symbology’s advancements, however, make tracking drugs through the supply chain to prevent the infiltration of foreign-made, knock-off drugs a reality.

In conjunction with Catalent Pharma Solutions, a major pharmaceutical manufacturer and packaging company, Secure Symbology has effectively employed its patented, fully-integrated Electronic Sequence Code (ESC) anti-counterfeiting system. With great success, this drug documentation and tracking methodology has been tested on Catalent’s various types of prescription drug packaging. Now, the system is available to pharmaceutical companies and packagers worldwide.

As pioneers of this technology, Secure Symbology is not only capable of assisting drug makers globally to put into operation safeguards that protect consumers but is geared to help the industry comply with California’s looming anti-counterfeiting mandate. This important legislation, which will go into effect on January 1, 2009, requires drugs being sold throughout the state to be tracked through a drug documentation system. California’s initiative is gaining the support of the public, consumer advocacy groups, legislators and pharmaceutical companies nationwide.

About Secure Symbology
Founded in 2003 and headquartered in northern New Jersey, Secure Symbology (securesymbology.com) has patented technology that offers a low-cost, reliable anti-counterfeiting solution. Its advanced bar code technology is the basis for its system that provides an electronic product pedigree and unit-level track-and-trace capability. Used by the pharmaceutical industry, Secure Symbology is expanding its reach to include the automotive, aeronautical and food manufacturers, in addition to luxury brands and consumer product manufacturers with their ever-increasing counterfeiting problems.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Rosica Strategic Public Relations

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Secure Symbology, Inc. Introduces New Technology – Protects Consumers from Counterfeit Prescription Drugs

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Debbie Gotthart - Rosica.com 
201-843-5600 debbie[.]rosica.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Rosica Strategic Public Relations securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Rosica Strategic Public Relations / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)